Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamel Bouraoui

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|March 24, 2007
Peginterferon and ribavirin for hepatitis CChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Lancet (London, England)|July 1, 2008
Management of acute organophosphorus pesticide poisoningHoussem Hmouda, Chaker Ben Salem, Kamel Bouraoui
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2008
Drug-induced hyponatremia: adding to the listChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
La Tunisie Medicale|February 3, 2005
[Current aspects and future perspectives of pharmacotherapy or type II diabetes]Choker Ben Salem, Bouraoui Elouni, Kamel Bouraoui
Lancet (London, England)|August 7, 2007
Acute lung injury and acute respiratory distress syndromeChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
British Journal of Clinical Pharmacology|February 28, 2007
Glimepiride-induced vasculitis: a case reportChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
The New England Journal of Medicine|October 23, 2009
PsoriasisChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Current Drug Safety|January 20, 2009
Drug-induced hypokalaemiaChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Archives of Internal Medicine|June 15, 2007
Treatment of MRSA infections with older molecules: a reasonable option for investigationHoussem Hmouda, Chaker Ben Salem, Kamel Bouraoui, et al.
Journal of Molecular Graphics & Modelling|July 28, 2014
In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamicsSofiene Larif, Chaker Ben Salem, Houssem Hmouda, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|March 24, 2007
Peginterferon and ribavirin for hepatitis CChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Lancet (London, England)|July 1, 2008
Management of acute organophosphorus pesticide poisoningHoussem Hmouda, Chaker Ben Salem, Kamel Bouraoui
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2008
Drug-induced hyponatremia: adding to the listChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
La Tunisie Medicale|February 3, 2005
[Current aspects and future perspectives of pharmacotherapy or type II diabetes]Choker Ben Salem, Bouraoui Elouni, Kamel Bouraoui
Lancet (London, England)|August 7, 2007
Acute lung injury and acute respiratory distress syndromeChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
British Journal of Clinical Pharmacology|February 28, 2007
Glimepiride-induced vasculitis: a case reportChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
The New England Journal of Medicine|October 23, 2009
PsoriasisChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Current Drug Safety|January 20, 2009
Drug-induced hypokalaemiaChaker Ben Salem, Houssem Hmouda, Kamel Bouraoui
Archives of Internal Medicine|June 15, 2007
Treatment of MRSA infections with older molecules: a reasonable option for investigationHoussem Hmouda, Chaker Ben Salem, Kamel Bouraoui, et al.
Journal of Molecular Graphics & Modelling|July 28, 2014
In silico screening and study of novel ERK2 inhibitors using 3D QSAR, docking and molecular dynamicsSofiene Larif, Chaker Ben Salem, Houssem Hmouda, et al.
Pageof 3